Synthesis and hypoglycemic activity of some new theophylline derivatives

References

• De Fronzo RA, Bonasonna RC, Ferrannini E. Pathogenesis of INDDM: a balanced overview. Diabetes Care 1992;15:318–68
   PubMed Web of Science ®Google Scholar
• Jacobson KA, van Galen PJ, Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 1992;35:407–22
   PubMed Web of Science ®Google Scholar
• Scaccianoce S, Navarra D, Di Sciullo A, et al. Adenosine and pituitary-adrenocortical axis activity in the rat. Neuroendocrinology 1989;50:464–8
   Google Scholar
• Schettini G, Landolfi E, Meucci O, et al. Adenosine and its analogue (−)-N6-phenylisopropyladenosine modulate anterior pituitary adenylate cyclase activity and prolactin secretion in the rat. J Mol Endocrinol 1990;5:69–76
   PubMed Web of Science ®Google Scholar
• Buxton DB, Fisher RA, Robertson SM, Olson MS. Stimulation of glycognolysis and vasoconstriction by adenosine and adenosine analogues in the perfused liver. Biochem J 1987;248:35–41
   PubMedGoogle Scholar
• Mclane MP, Black PR, Law WR, Raymond RM. Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes 1990;39:62–9
   PubMedGoogle Scholar
• Chaliss RAJ, Budohiski L, MacManus B, Newsholme EA. Effects of an adenosine receptor antagonist in insulin resistance in Soleus Muscle from Obese Zucker rats. Biochem J 1984;221:915–17
   Google Scholar
• Crist GH, LaNoue KF, Lang CH. Tissue-specific effects of in vivo adenosine receptor blockage on glucose uptake in Zucker rats. FASEB J 1998;12:1301–8
   PubMed Web of Science ®Google Scholar
• Camaioni E, Costanzi S, Vittori S, et al. New substituted 9-alkylpurinies as adenosine receptor ligands. Bioorg Med Chem. 1998;6:523–33
   PubMed Web of Science ®Google Scholar
• Harada H, Asano O, Hoshino Y, et al. 2-Alkynyl-8-aryl-9-methyladenine as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A2B receptors. J Med Chem 2001;44:170–9
   PubMed Web of Science ®Google Scholar
• Jeong LS, Choe SA, Kim AY, et al. Synthesis of N6-substituted 3′-ureidoadenosine derivatives as highly potent agonists at the mutant A3 adenosine receptor. Nucleosides Nucleotides Nucleic Acids 2007;26:717–19
   PubMed Web of Science ®Google Scholar
• Stefanachi A, Nicolotti O, Leonetti F, et al. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships. Bioorg Med Chem 2008;16:9780–9
   Google Scholar
• Katyal J, Gupta YK. Dopamine release is involved in antinociceptive effect of theophylline. Int J Neurosci 2012;122:17–21
   PubMed Web of Science ®Google Scholar
• Hierrezuelo J, Manuel López-Romero J, Rico R, et al. Synthesis of theophylline derivatives and study of their activity as antagonists at adenosine receptors. Bioorg Med Chem 2010;18:2081–8
   Google Scholar
• Watanabe S, Yamakami J, Tsuchiya M, et al. Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system. J Pharmacol Sci 2008;106:566–70
   Google Scholar
• Hasegawa M, Hada J, Abe T, et al. Theophylline attenuates hippocampal blood flow responses induced by tooth pulp stimulation in rats. Neurosci Res 2009;65:156–9
   PubMed Web of Science ®Google Scholar
• Cunha RA, Ferré S, Vaugeois JM, Chen JF. Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 2008;14:1512–24
   PubMed Web of Science ®Google Scholar
• Umrani DN, Goyal RK. Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats. Clin Exp Hypertens 2002;24:207–19
   PubMed Web of Science ®Google Scholar
• Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol 2004;56:101–5
   PubMed Web of Science ®Google Scholar
• Majithiya JB, Balaraman R. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci 2006;78:2615–24
   PubMed Web of Science ®Google Scholar
• Tayek JA. Low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation. Am J Med Sci 1995;309:134–9
   Google Scholar
• El Tahir KE, Williams KI, Betteridge DJ. The effect of experimental diabetes on prostacyclin production by tissues from pregnant rats. Prostaglandins Leukot Med 1982;8:429–35
   Google Scholar